Articles by tag: Pfizer

Pfizer CEO Bourla on Covid Vaccine, R&D, Reopening

Pfizer CEO Bourla on Covid Vaccine, R&D, Reopening
Pfizer CEO Albert Bourla, DVM, PH.D. was on the forefront of the global recovery from the COVID 19 pandemic. Pfizer helped lead the way to a vaccine, but Bourla has even higher ambitions for the Read more

Latest

Identifying Lightning Damage on Pecan Trees
Identifying Lightning Damage on Pecan Trees: Tips from TreeNewal
June 7, 2023

Join ISA Certified Arborist Wes Rivers from TreeNewal as he examines the aftermath of lightning damage on a pecan tree. In this insightful video, Wes highlights the path taken by the lightning bolt through the tree, causing superheating of the water inside. The resulting vapor expansion creates visible damage to the tree. The tree’s survival […]

Read More
Health Plan
Transforming Coverage to Meet Healthcare Needs with SCAN Health Plan
June 7, 2023

John Petito, SVP of Transformation at SCAN Health Plan joins the podcast to share his story and how his work is helping enable new types of healthcare coverage for diverse populations. Join us to hear how Health Plans are beginning to evolve their approach to addressing the needs of older adults and the LGBTQ+ community […]

Read More
Finding your identity
Finding Your Identity with Dustin Odham
June 6, 2023

In an era where screens dominate our time, finding your personal identity becomes a challenge. Our generation is shaping itself based on an increasingly virtual world, often losing touch with the inner self. In fact, a recent study suggests that we could end up spending at least ten years of our life in front of […]

Read More
All Articles
Pfizer CEO Bourla on Covid Vaccine, R&D, Reopening
June 21, 2021

Pfizer CEO Albert Bourla, DVM, PH.D. was on the forefront of the global recovery from the COVID 19 pandemic. Pfizer helped lead the way to a vaccine, but Bourla has even higher ambitions for the company. Watch below as Bourla addresses the possibilities that lie ahead for Pfizer, and his goals to impact the medical […]

Read More
A Pulmonary Expert Weighs in on the Johnson & Johnson COVID-19 Vaccine’s Pause
April 28, 2021

The mission of Health Matters is to promote health equity by elevating the conversation around healthy habits, preventative health, and relevant public health issues. By approaching these topics with an equitable lens, we can all do our part to empower individuals to make more informed decisions about their health and care.   On this episode, […]

Read More
Biden to Order 100 Million More J&J Doses, Boosting Supply
March 10, 2021

(Bloomberg) President Joe Biden said doubling the U.S. order of Johnson & Johnson’s one-shot Covid-19 vaccine will help build a stockpile larger than the country’s population, providing backup doses to meet unexpected needs as new variants of the virus emerge. After the U.S. is satisfied that it has enough supply to meet contingencies it will […]

Read More
Dry Ice Becomes a Must for COVID Vaccine Distribution
December 17, 2020

As the world eagerly awaits the manufacture and distribution of the COVID vaccine, many are considering the many steps that will be needed to deliver these vital vials of medication to the hospitals and pharmacies where they’ll be injected. Moderna’s vaccine has to be shipped at -4˚F, then can be stored at that temperature […]

Read More
Pfizer CEO Profits After COVID Vaccine Announcement
November 30, 2020

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale […]

Read More
Pfizer’s COVID Vaccine Shows Promising Results
November 16, 2020

America is desperate for some optimism in the fight against COVID-19, and on Monday Pfizer delivered. The pharmaceutical company’s initial COVID vaccine, developed in partnership with the BioNTech, released findings that the vaccine was 90% effective in early tests. Though more testing is needed, the news is a bright spot, and the science community is […]

Read More
Should the COVID Vaccine Turn a Big Profit for Big Pharma?
July 31, 2020

Powered by RedCircle In the latest news on the coronavirus, Business Casual hosts Daniel Litwin and Tyler Kern analyze Pfizer CEO Albert Bourla’s recent statement about the ethics behind profiting off of a COVID vaccine. As the government doles out taxpayer dollars to the private sector in the race for a cure, should the resulting […]

Read More